Details of Viral Vaccine
This Viral vaccine card gives comprehensive information about each vaccine.
| Detailed Information | |
|---|---|
| ID | 10092 |
| Vaccine Name | HAVRIX |
| Disease Name | Hepatitis A |
| Disease Classification | Hepatitic |
| Virus Name | Hepatitis A virus |
| Nucleic Acid Content | positive-sense, single-stranded RNA |
| Vaccine Type | Inactivated |
| Vaccine Status | Approved |
| Manufacturer | GlaxoSmithKline |
| Year of Manufacturing | NA |
| Manufacturing Country | Belgium |
| Age | NA |
| Dosage | P: 720 EU; Adults: 1440 EU; 2 doses 0, 6–12 |
| Administration Route | Intramuscular |
| Adjuvant | Aluminum (aluminium hydroxide) |
| Target Strain | HM-175 |
| Description | NA |
| Approving Organisation | US FDA |
| Collaborating Organisation | NA |
| Other Countries | NA |
| Trade Name | NA |
| PMID | 29661808 |
| Clinical Trial ID | NA |
| Reference Link | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6360863/ |
| Additional Links | https://www.fda.gov/files/vaccines%2C%20blood%20%26%20biologics/published/Package-Insert---HAVRIX.pdf |